microXpace's mission is to put advanced microbial applications at the frontline of the 'One Health' initiative.
Please enter subscribe form shortcode
Please enter instagram feed shortcode
Gut beneficial bacteria have co-evolved with their vertebrate hosts, including fish, over millions of years. This enduring symbiotic relationship has thrived through natural selection because these microbiota offer crucial protection against significant threats, notably infectious diseases. A key component of this interaction involves the bacteria in the gut microbiota producing the glycan alpha-Gal, which in turn stimulates the host to generate natural anti-alpha-Gal antibodies.
Recently, a team of researchers—including several co-founders of microXpace—made a groundbreaking discovery regarding these antibodies. They found that natural anti-alpha-Gal antibodies have the capability to neutralize major pathogens affecting fish. This research has also paved the way for innovations in modulating the natural immune response to alpha-Gal. By enhancing this response, it is possible to prime the fish's immune system, putting it into a 'ready-to-fight' state that offers protection against multiple pathogens simultaneously.
microXpace, in collaboration with our biotech partner Lallemand, is leveraging patented technology to develop a suite of products designed to simultaneously protect fish from major parasitic and infectious diseases. Our flagship product, AquaGalX, is an environmentally friendly feed additive that is completely safe for use. Extensively tested across various fish species, AquaGalX has demonstrated significant efficacy in controlling anemia induced by parasites. This allows fish not only to maintain health but also to grow and gain weight more effectively.